Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Dave Amerson?

Dave Amerson

President and Chief Executive Officer

NeoTract Inc

HQ Phone:  (925) 401-0700

Direct Phone: (925) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

NeoTract Inc

4473 WILLOW RD

Pleasanton, California,94588

United States

Company Description

NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. The company's initial focus is on improving the standard of care for patients with BPH using the UroLift... more.

Find other employees at this company (176)

Background Information

Employment History

General Manager for the Surgical Urology Division

Coloplast Corp


Affiliations

EMKinetics

Board Member


The Urology Society of America

Board Member


American Lithotripsy Society

Board Member


Education

B.A.

Political Science

University of West Georgia


M.B.A.

Argosy University


Web References(69 Total References)


Leadership Team – UroLift

urolift.com [cached]

Dave Amerson - President and CEO, NeoTract, Inc.
Dave Amerson Dave is President and CEO of NeoTract, Inc., a medical device company focused on shifting the treatment paradigm in urology. Under his leadership, NeoTract received FDA De Novo clearance for the UroLift® System, a minimally invasive technology to treat symptoms of benign prostatic hyperplasia (BPH). He also led the company to achieve critical reimbursement milestones, including new CPT 1 codes, a New Tech APC code and a national coverage policy by Aetna for the UroLift System. Internationally, NeoTract has achieved positive NICE guidance for the UroLift System in the UK and a prosthesis code with payment for the UroLift implant in Australia. Dave joined NeoTract in 2011, bringing over 25 years of management experience in the medical device field with an emphasis in urology. Prior to NeoTract, Dave was Global Vice President; General Manager for the Coloplast Surgical Urology division. Dave began his career at Osbon Medical Systems. He is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


www.urolift.com

David Amerson - President and Chief Executive Officer.
Dave joined NeoTract in July 2011 as President and CEO. He brings over 25 years of management experience in the medical device field with an emphasis in urology. Most recently, Dave served as Global Vice President, General Manager for the Coloplast Surgical Urology division and was Chairman of the Surgical Urology Leadership Team. In these roles, he was responsible for Sales, Marketing, Quality/Regulatory, R&D, Clinical Studies, Manufacturing and Legal. In 2006, Dave was the point person for the divestiture of Mentor's urology business unit that was acquired by Coloplast Corporation for $463M. Post-acquisition, Dave led the Global Surgical Urology division at Coloplast to achieve double digit sales growth and launch several innovative new products. Dave began his career at Osbon Medical Systems where he built a successful sales and marketing team that achieved aggressive sales growth. Osbon Medical was acquired by Urohealth Systems, Inc. in 1995 for $44M. Dave is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


NeoTract Board of Directors

www.neotract.com [cached]

David Amerson â€" President and Chief Executive Officer.Â
Dave joined NeoTract in July 2011 as President and CEO. He brings over 25 years of management experience in the medical device field with an emphasis in urology. Most recently, Dave served as Global Vice President, General Manager for the Coloplast Surgical Urology division and was Chairman of the Surgical Urology Leadership Team. In these roles, he was responsible for Sales, Marketing, Quality/Regulatory, R&D, Clinical Studies, Manufacturing and Legal. In 2006, Dave was the point person for the divestiture of Mentor’s urology business unit that was acquired by Coloplast Corporation for $463M. Post-acquisition, Dave led the Global Surgical Urology division at Coloplast to achieve double digit sales growth and launch several innovative new products. Dave began his career at Osbon Medical Systems where he built a successful sales and marketing team that achieved aggressive sales growth. Osbon Medical was acquired by Urohealth Systems, Inc. in 1995 for $44M. Dave is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


healthegy.com

Dave Amerson
Dave Amerson CEO NeoTract, Inc. Dave is President and CEO of NeoTract, Inc., a medical device company focused on shifting the treatment paradigm in urology. Under his leadership, NeoTract received FDA De Novo clearance for the UroLift® System, a minimally invasive technology to treat symptoms of benign prostatic hyperplasia (BPH). He also led the company to achieve critical reimbursement milestones, including new CPT 1 codes, a New Tech APC code and a national coverage policy by Aetna for the UroLift System. Internationally, NeoTract has achieved positive NICE guidance for the UroLift System in the UK and a prosthesis code with payment for the UroLift implant in Australia. Dave joined NeoTract in July 2011, bringing over 25 years of management experience in the medical device field with an emphasis in urology. Prior to NeoTract, Dave was Global Vice President; General Manager for the Coloplast Surgical Urology division. Dave began his career at Osbon Medical Systems. He is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an MBA from Argosy University and a BA in Political Science from the University of West Georgia.


About Neotract : NeoTract in the News

www.neotract.com [cached]

8. Dave Amerson elected President and CEO of NeoTract, Inc.
Read the press release.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory